Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 83Recruiting 35Active not recruiting 33Terminated 25Unknown 8Withdrawn 4Not yet recruiting 4Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

enzalutamide 1dynorphin-converting endopeptidase 1Surveys and Questionnaires 1Specimen Handling 1Radiosurgery 1Magnetic Resonance Imaging 1Inosine Monophosphate 1Genetic Testing 1Genetic Counseling 1Fluorodeoxyglucose F18 1Brachytherapy 1Biopsy 1Antibiotic Prophylaxis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Prostatic Neoplasms × enzalutamide × Clear all
NCT04145375 2026-05-08

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Zenith Epigenetics

Phase 1/2 Enrolling by invitation
40 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡